Search Results - "Senra, Juliana"

Treatment with Benznidazole during the Chronic Phase of Experimental Chagas' Disease Decreases Cardiac Alterations by Garcia, Simone, Ramos, Carolina O, Senra, Juliana F V, Vilas-Boas, Fabio, Rodrigues, Maurício M, Campos-de-Carvalho, Antonio C, Ribeiro-Dos-Santos, Ricardo, Soares, Milena B P

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Potassium-competitive acid blockers, a new therapeutic class, and their role in acid-related diseases: a narrative review by Domingues, Gerson, Chinzon, Decio, Moraes-Filho, Joaquim Prado P, Senra, Juliana Tosta, Perrotti, Marcos, Zaterka, Schlioma

“…A new therapeutic class, potassium-competitive acid blockers (P-CABs), has emerged in Brazil to promote a superior antisecretory effect addressing the unmet…”
Get full text

A real-world study of hereditary angioedema patients due to C1 inhibitor deficiency treated with danazol in the Brazilian Public Health System by Ritter, Alessandra Mileni Versuti, Silva, Suelen, de Paula, Robson, Senra, Juliana, Carvalho, Fabio, Ribeiro, Tatiane, Valle, Solange Oliveira Rodrigues

“…Hereditary angioedema (HAE) due to C1 inhibitor (C1-INH) deficiency is an ultra-rare autosomal dominant inherited disease that affects 1 in 67,000 people in…”
Get full text

Real-world treatment patterns and disease control over one year in patients with inflammatory bowel disease in Brazil by Sassaki, Ligia Yukie, Miszputen, Sender J, Kaiser Junior, Roberto Luiz, Catapani, Wilson R, Bafutto, Mauro, Scotton, António S, Zaltman, Cyrla, Baima, Julio Pinheiro, Ramos, Hagata S, Faria, Mikaell Alexandre Gouvea, Gonçalves, Carolina D, Guimaraes, Isabella Miranda, Flores, Cristina, Amarante, Heda M B S, Nones, Rodrigo Bremer, Parente, José Miguel Luz, Lima, Murilo Moura, Chebli, Júlio Maria, Ferrari, Maria de Lourdes Abreu, Campos, Julia F, Sanna, Maria G P, Ramos, Odery, Parra, Rogério Serafim, da Rocha, Jose J R, Feres, Omar, Feitosa, Marley R, Caratin, Rosana Fusaro, Senra, Juliana, Santana, Genoile Oliveira

“…BACKGROUNDCrohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBDs) with a remission-relapsing presentation and symptomatic…”
Get full text

Caspase inhibition reduces lymphocyte apoptosis and improves host immune responses to Trypanosoma cruzi infection by Silva, Elisabeth M., Guillermo, Landi V. C., Ribeiro‐Gomes, Flávia L., De Meis, Juliana, Nunes, Marise P., Senra, Juliana F. V., Soares, Milena B. P., DosReis, George A., Lopes, Marcela F.

“…In experimental Chagas’ disease, lymphocytes from mice infected with Trypanosoma cruzi show increased apoptosis in vivo and in vitro. Treatment with a…”
Get full text

Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil by Parra, Rogerio S, Chebli, Julio M F, Amarante, Heda M B S, Flores, Cristina, Parente, Jose M L, Ramos, Odery, Fernandes, Milene, Rocha, Jose J R, Feitosa, Marley R, Feres, Omar, Scotton, Antonio S, Nones, Rodrigo B, Lima, Murilo M, Zaltman, Cyrla, Goncalves, Carolina D, Guimaraes, Isabella M, Santana, Genoile O, Sassaki, Ligia Y, Hossne, Rogerio S, Bafutto, Mauro, Junior, Roberto L K, Faria, Mikaell A G, Miszputen, Sender J, Gomes, Tarcia N F, Catapani, Wilson R, Faria, Anderson A, Souza, Stella C S, Caratin, Rosana F, Senra, Juliana T, Ferrari, Maria L A

“…Inflammatory bowel diseases (IBD) have been associated with a low quality of life (QoL) and a negative impact on work productivity compared to the general…”
Get full text

Real world data study of prevalence and direct costs related to dengue management in Brazil's private healthcare from 2015 to 2020 by Abud, Denise Alves, Santos, Claudia Yang, Neto, Abner Augusto Lobao, Senra, Juliana Tosta, Tuboi, Suely

“…The burden of dengue in Brazil is poorly documented and is based on data from the public health care setting. This study estimated the prevalence and costs of…”
Get full text

PREVALÊNCIA E CUSTOS DIRETOS RELACIONADOS AO MANEJO DA DENGUE NA SAÚDE PRIVADA DO BRASIL by Abud, Denise Alves, Santos, Claudia Yang, Neto, Abner Lobao, Senra, Juliana Tosta, Tuboi, Suely

Get full text

A Brazilian Real-Life Experience of Multiple Myeloma Patients: Final Results from the Mmybrave Multi-Center Study by Hungria, Vania T.M., Bittencourt, Rosane, Martinez, Gracia, Santos, Juliana De Andrade, Almeida, Denise Ramos de, Figueiredo, Vera Lúcia De Piratininga, De Farias, Danielle Leao Cordeiro, Zanella, Karla Richter, Muniz, Larissa Barchi, Carvalho, Pedro, Senra, Juliana, Abreu, Rodrigo Martins, Mattos, Éderson Roberto

Get full text

Brazilian Real-Life Experience of Multiple Myeloma (MMyBRAve): Improvement in Outcomes, But Remaining Diagnostic and Therapeutic Gaps by Hungria, Vania, Bittencourt, Rosane Isabel, Martinez, Gracia Aparecida, Santos, Juliana de Andrade, de Almeida, Denise Ramos, Figueiredo, Vera Lucia de Piratininga, de Farias, Danielle Leão Cordeiro, Zanella, Karla Richter, Muniz, Larissa Barchi, Senra, Juliana Tosta, Abreu, Rodrigo Martins, Mattos, Éderson Roberto

“…This study aimed at describing the demographic and clinical characteristics, treatment patterns and overall survival of patients with MM in Brazil to identify…”
Get full text

P-117: Multiple Myeloma treatment patterns and outcomes in the public and private healthcare systems in Brazil: one country, two worlds by Hungria, Vania, Bittencourt, Rosane, Martinez, Gracia, santos, Juliana, Almeida, Denise, Figueiredo, Vera, Farias, Danielle, Zanella, Karla, Muniz, Larissa, Mendonça, Diego, Abreu, Rodrigo, Senra, Juliana, Mattos, Ederson

“…Over the past two decades, the approval of several novel drugs has broadened therapeutic options for multiple myeloma (MM) patients, but has also raised…”
Get full text

PREVALÊNCIA E CUSTOS DIRETOS RELACIONADOS AO MANEJO DA DENGUE NA SAÚDE PRIVADA DO BRASIL by Denise Alves Abud, Claudia Yang Santos, Abner Lobao Neto, Juliana Tosta Senra, Suely Tuboi

“…Introdução: Existe uma relação entre baixo nível sócio econômico e elevado risco de dengue. O sistema Brasileiro de Saúde Suplementar atende cerca de 25% da…”
Get full text